<DOC>
	<DOC>NCT00560209</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for coronary angiography, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.</brief_summary>
	<brief_title>Study of ONO-1101 in Patients Scheduled for Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Landiolol</mesh_term>
	<criteria>20 years of age or older Heart rate less than 90 beats/min and more than 70 beats/min at entering the CT room Previous allergic reactions to contrast agent Renal failure Asthma Concomitant betareceptor blocking agent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-1101</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Multi-slice CT</keyword>
</DOC>